153 related articles for article (PubMed ID: 37895007)
41. FGF23 regulates renal sodium handling and blood pressure.
Andrukhova O; Slavic S; Smorodchenko A; Zeitz U; Shalhoub V; Lanske B; Pohl EE; Erben RG
EMBO Mol Med; 2014 Jun; 6(6):744-59. PubMed ID: 24797667
[TBL] [Abstract][Full Text] [Related]
42. Endothelin receptor B controls the production of fibroblast growth factor 23.
Feger M; Ewendt F; Menzel M; Hocher B; Föller M
FASEB J; 2020 May; 34(5):6262-6270. PubMed ID: 32157737
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23.
Yu X; Ibrahimi OA; Goetz R; Zhang F; Davis SI; Garringer HJ; Linhardt RJ; Ornitz DM; Mohammadi M; White KE
Endocrinology; 2005 Nov; 146(11):4647-56. PubMed ID: 16081635
[TBL] [Abstract][Full Text] [Related]
44. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
[TBL] [Abstract][Full Text] [Related]
45. Inappropriate secretion of fibroblast growth factor 23 despite hypophosphataemia with changes in bone turnover markers in a girl with systemic lupus erythematosus: Case report and review of the literature.
Kawaguchi T; Inamo Y
Mod Rheumatol Case Rep; 2023 Jan; 7(1):60-64. PubMed ID: 35792508
[TBL] [Abstract][Full Text] [Related]
46. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
47. [Hormonal regulation of phosphate balance].
Tanaka H; Fukagawa M
Clin Calcium; 2012 Oct; 22(10):1477-85. PubMed ID: 23023626
[TBL] [Abstract][Full Text] [Related]
48. Oral Acid Load Down-Regulates Fibroblast Growth Factor 23.
Vidal A; Pineda C; Raya AI; Rios R; Espartero A; Muñoz-Castañeda JR; Rodriguez M; Aguilera-Tejero E; Lopez I
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35268016
[TBL] [Abstract][Full Text] [Related]
49. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
[TBL] [Abstract][Full Text] [Related]
50. Fibroblast growth factor 23 concentrations and modifying factors in children from age 12 to 24 months.
Enlund-Cerullo M; Hauta-Alus H; Valkama S; Rosendahl J; Andersson S; Mäkitie O; Holmlund-Suila E
Bone; 2020 Dec; 141():115629. PubMed ID: 32919110
[TBL] [Abstract][Full Text] [Related]
51. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.
Daryadel A; Bettoni C; Haider T; Imenez Silva PH; Schnitzbauer U; Pastor-Arroyo EM; Wenger RH; Gassmann M; Wagner CA
Pflugers Arch; 2018 Oct; 470(10):1569-1582. PubMed ID: 29961920
[TBL] [Abstract][Full Text] [Related]
52. Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling.
Egli-Spichtig D; Zhang MYH; Li A; Pastor Arroyo EM; Hernando N; Wagner CA; Chang W; Perwad F
Sci Rep; 2021 Mar; 11(1):6175. PubMed ID: 33731726
[TBL] [Abstract][Full Text] [Related]
53. Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance Biosensor.
Lu J; Spasic D; Delport F; Van Stappen T; Detrez I; Daems D; Vermeire S; Gils A; Lammertyn J
Anal Chem; 2017 Mar; 89(6):3664-3671. PubMed ID: 28222600
[TBL] [Abstract][Full Text] [Related]
54. An Immunosensor for the Determination of Cathepsin S in Blood Plasma by Array SPRi-A Comparison of Analytical Properties of Silver-Gold and Pure Gold Chips.
Falkowski P; Mrozek P; Lukaszewski Z; Oldak L; Gorodkiewicz E
Biosensors (Basel); 2021 Aug; 11(9):. PubMed ID: 34562888
[TBL] [Abstract][Full Text] [Related]
55. The parathyroid is a target organ for FGF23 in rats.
Ben-Dov IZ; Galitzer H; Lavi-Moshayoff V; Goetz R; Kuro-o M; Mohammadi M; Sirkis R; Naveh-Many T; Silver J
J Clin Invest; 2007 Dec; 117(12):4003-8. PubMed ID: 17992255
[TBL] [Abstract][Full Text] [Related]
56. Advances in understanding of phosphate homeostasis and related disorders.
Michigami T
Endocr J; 2022 Aug; 69(8):881-896. PubMed ID: 35831119
[TBL] [Abstract][Full Text] [Related]
57. Fibroblast Growth Factor 23 as Regulator of Vitamin D Metabolism.
Nakatani S; Nakatani A; Mori K; Emoto M; Inaba M; Razzaque MS
Adv Exp Med Biol; 2022; 1362():47-54. PubMed ID: 35288872
[TBL] [Abstract][Full Text] [Related]
58. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
Phelps KR; Mason DL
Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
[TBL] [Abstract][Full Text] [Related]
59. Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels.
Ohya M; Yashiro M; Sonou T; Okuda K; Tatsuta K; Mima T; Tone Y; Negi S; Saika Y; Shigematsu T
Contrib Nephrol; 2018; 196():44-51. PubMed ID: 30041203
[TBL] [Abstract][Full Text] [Related]
60. Bone-kidney axis in systemic phosphate turnover.
Razzaque MS
Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
